Clinical Trial Details
Braintumor Website

[Information provided by:, which provides patients, family members, and members of the public easy and free access to information on clinical studies for a wide range of diseases and conditions.]

NCT02296580 : A Feasibility Study of the Nativis Voyager® System in Patients With Recurrent Glioblastoma Multiforme (GBM)
AgesMin: 18 Years Max: N/A
Inclusion Criteria:

- Subject has histologically confirmed diagnosis of GBM.

- Subject has failed or intolerant to radiotherapy.

- Subjects has failed or intolerant to temozolomide therapy.

- Subject has progressive disease with at least one measureable lesion on MRI.

- Subject is at least 18 years of age.

- Subject has a KPS ? 60.

- Subject has adequate organ and marrow function.

Exclusion Criteria:

- Subject has received bevacizumab (Avastin).

- Subjecting has any condition, including compromised pulmonary function, that would
preclude the use of lomustine.

- Subject is currently being treated with other investigational agents.

- Subject has received other investigational therapy within the last 28 days.

- Subject has received surgery within the last four weeks.

- Subject is within 12 weeks of completion of radiation.

- Subject has an active implantable or other electromagnetic device.

- Subject has a metal implant, including a programmable shunt, in the head or neck that
is incompatible with MRI.

- Subject is known to be HIV positive.

- Subject is pregnant, nursing or intends to become pregnant during the course of the
LinksPermanent Link to THIS page:      |      Link to official listing

Facility: St Vincent's Hospital Melbourne
Investigator: Michael Murphy, MD
Contact: Emma Priest Phone: 03 9231 3551
Click HERE to send email to this center

Birmingham, Alabama
Facility: University of Alabama at Birmingham (UAB)
Investigator: Burt Nabors, MD
Contact: Thiru Pillay, RN BSN Phone: 205-934-1842
Click HERE to send email to this center

Tucson, Arizona
Facility: Center for Neurosciences
Investigator: Michael Badruddoja, MD
Contact: Margie Pazzi, RN, MSN Phone: 520-320-2147
Click HERE to send email to this center

Encinitas, California
Facility: cCARE - California Cancer Associates for Research & Excellence
Investigator: Edward McClay, MD
Contact: Beth Kimball Phone: 760-452-3909
Click HERE to send email to this center

Santa Monica, California
Facility: John Wayne Cancer Institute @ Providecne St. Johns Health Center
Investigator: Garni Barkhoudarian, MD
Contact: Anand Moses Phone: 310-582-7097
Click HERE to send email to this center

Fairfield, Connecticut
Facility: Associated Neurologists of Southern CT, P.C.
Investigator: Nicholas Blondin, MD
Contact: Tori Pascoe, CRC Phone: 203-333-1151
Click HERE to send email to this center

Boca Raton, Florida
Facility: Boca Raton Regional Hospital
Investigator: Sajeel Chowdhary, MD
Contact: Pilar Zuniga, MD Phone: 561-955-4800
Click HERE to send email to this center

Kansas City, Kansas
Facility: University of Kansas Medical Center (KUMC)
Investigator: Michael Salacz, MD
Contact: Sasha Moores Phone: 913-588-5520
Click HERE to send email to this center

Austin, Texas
Facility: Cancer Care Collaborative
Investigator: Brian D Vaillant, MD
Contact: Heidi Herndon, RN Phone: 512-324-7000
Click HERE to send email to this center

Temple, Texas
Facility: Baylor Scott & White Health
Investigator: Ekokobe Fonkem, DO
Contact: Dedra Preece, BS, CCRP Phone: 254-724-5939
Click HERE to send email to this center

Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2018 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557

Website Design By
World Wide Websites